 Irina Petrache
Concepts (587)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Emphysema | 35 | 2024 | 275 | 9.960 |
Why?
| | Ceramides | 23 | 2023 | 112 | 5.110 |
Why?
| | alpha 1-Antitrypsin | 15 | 2023 | 107 | 5.080 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 24 | 2024 | 998 | 4.700 |
Why?
| | Lung | 54 | 2025 | 3928 | 4.490 |
Why?
| | Endothelial Cells | 25 | 2025 | 739 | 4.280 |
Why?
| | Smoking | 30 | 2020 | 1501 | 3.980 |
Why?
| | Apoptosis | 38 | 2020 | 2488 | 3.530 |
Why?
| | Cigarette Smoking | 8 | 2022 | 91 | 3.430 |
Why?
| | Lung Injury | 11 | 2023 | 211 | 3.390 |
Why?
| | Smoke | 12 | 2021 | 140 | 3.090 |
Why?
| | Electronic Nicotine Delivery Systems | 7 | 2023 | 90 | 2.880 |
Why?
| | Emphysema | 10 | 2023 | 109 | 2.470 |
Why?
| | Sphingolipids | 7 | 2018 | 72 | 2.240 |
Why?
| | alpha 1-Antitrypsin Deficiency | 8 | 2019 | 67 | 2.190 |
Why?
| | Pulmonary Alveoli | 15 | 2018 | 403 | 2.130 |
Why?
| | Macrophages, Alveolar | 5 | 2021 | 389 | 2.100 |
Why?
| | Vaping | 3 | 2023 | 55 | 1.590 |
Why?
| | Sphingomyelin Phosphodiesterase | 6 | 2023 | 22 | 1.510 |
Why?
| | Endothelium, Vascular | 11 | 2023 | 895 | 1.420 |
Why?
| | Animals | 88 | 2025 | 35334 | 1.410 |
Why?
| | Tobacco Products | 5 | 2021 | 110 | 1.390 |
Why?
| | Microvessels | 4 | 2021 | 81 | 1.360 |
Why?
| | Hypertension, Pulmonary | 9 | 2025 | 1891 | 1.360 |
Why?
| | Mice | 57 | 2024 | 16973 | 1.340 |
Why?
| | Signal Transduction | 19 | 2020 | 4916 | 1.240 |
Why?
| | Oxidative Stress | 13 | 2020 | 1261 | 1.230 |
Why?
| | Cells, Cultured | 23 | 2021 | 4087 | 1.200 |
Why?
| | Autophagy | 7 | 2021 | 265 | 1.180 |
Why?
| | Acute Lung Injury | 3 | 2021 | 280 | 1.160 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2017 | 1203 | 1.160 |
Why?
| | Alveolar Epithelial Cells | 3 | 2018 | 107 | 1.130 |
Why?
| | Disease Models, Animal | 16 | 2022 | 4073 | 1.090 |
Why?
| | Mice, Inbred C57BL | 27 | 2022 | 5468 | 1.050 |
Why?
| | Pneumonia | 5 | 2021 | 618 | 1.030 |
Why?
| | Caspase 3 | 7 | 2016 | 244 | 1.000 |
Why?
| | Receptors, Estrogen | 3 | 2014 | 421 | 0.990 |
Why?
| | Pulmonary Artery | 10 | 2022 | 1075 | 0.970 |
Why?
| | Membrane Proteins | 5 | 2022 | 1118 | 0.960 |
Why?
| | Hypoxia | 6 | 2020 | 1081 | 0.940 |
Why?
| | Adipose Tissue | 5 | 2017 | 594 | 0.940 |
Why?
| | MicroRNAs | 2 | 2022 | 677 | 0.920 |
Why?
| | Humans | 100 | 2025 | 129527 | 0.910 |
Why?
| | Rats | 22 | 2017 | 5470 | 0.900 |
Why?
| | Neovascularization, Physiologic | 3 | 2020 | 173 | 0.890 |
Why?
| | Tobacco Smoke Pollution | 4 | 2018 | 231 | 0.890 |
Why?
| | Up-Regulation | 10 | 2020 | 832 | 0.890 |
Why?
| | Endothelium | 4 | 2023 | 120 | 0.890 |
Why?
| | Endocytosis | 3 | 2016 | 162 | 0.870 |
Why?
| | Vascular System Injuries | 1 | 2023 | 73 | 0.780 |
Why?
| | Phagocytosis | 3 | 2021 | 362 | 0.730 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 4 | 0.730 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 4 | 0.730 |
Why?
| | Lysophospholipase | 1 | 2021 | 10 | 0.730 |
Why?
| | Rats, Sprague-Dawley | 14 | 2018 | 2393 | 0.700 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2020 | 15 | 0.670 |
Why?
| | Translocation, Genetic | 1 | 2020 | 92 | 0.670 |
Why?
| | Glucosylceramides | 1 | 2019 | 6 | 0.660 |
Why?
| | Immunoglobulins | 1 | 2020 | 162 | 0.650 |
Why?
| | Hyaluronic Acid | 2 | 2020 | 216 | 0.640 |
Why?
| | Estradiol | 3 | 2018 | 492 | 0.630 |
Why?
| | Epithelial Cells | 10 | 2022 | 1061 | 0.620 |
Why?
| | Glycoproteins | 1 | 2021 | 338 | 0.620 |
Why?
| | Mice, Knockout | 11 | 2021 | 2887 | 0.620 |
Why?
| | Macrophages | 4 | 2021 | 1486 | 0.610 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2019 | 26 | 0.610 |
Why?
| | Enzyme Inhibitors | 4 | 2018 | 825 | 0.610 |
Why?
| | Influenza, Human | 2 | 2022 | 602 | 0.600 |
Why?
| | Antibodies, Neutralizing | 2 | 2019 | 265 | 0.590 |
Why?
| | Alpha-Globulins | 1 | 2018 | 20 | 0.590 |
Why?
| | Lysosomes | 2 | 2021 | 137 | 0.590 |
Why?
| | Heterocyclic Compounds | 1 | 2018 | 18 | 0.590 |
Why?
| | Lung Diseases | 4 | 2025 | 741 | 0.580 |
Why?
| | Xeroderma Pigmentosum | 1 | 2018 | 7 | 0.580 |
Why?
| | Neoplasm Proteins | 5 | 2019 | 417 | 0.580 |
Why?
| | Sphingosine | 5 | 2015 | 40 | 0.580 |
Why?
| | Oncostatin M | 1 | 2017 | 6 | 0.570 |
Why?
| | RNA-Binding Proteins | 5 | 2019 | 388 | 0.570 |
Why?
| | Sphingosine N-Acyltransferase | 2 | 2018 | 5 | 0.570 |
Why?
| | Bronchoalveolar Lavage Fluid | 7 | 2018 | 646 | 0.560 |
Why?
| | Metformin | 1 | 2021 | 316 | 0.560 |
Why?
| | Thorax | 2 | 2022 | 45 | 0.550 |
Why?
| | Cell Death | 4 | 2019 | 352 | 0.520 |
Why?
| | Multiprotein Complexes | 1 | 2018 | 154 | 0.520 |
Why?
| | Cell Movement | 4 | 2020 | 942 | 0.520 |
Why?
| | Inflammation | 8 | 2024 | 2741 | 0.520 |
Why?
| | DNA Repair | 1 | 2018 | 210 | 0.510 |
Why?
| | Male | 44 | 2024 | 63586 | 0.510 |
Why?
| | Scavenger Receptors, Class B | 1 | 2015 | 11 | 0.480 |
Why?
| | Genetic Predisposition to Disease | 3 | 2020 | 2271 | 0.480 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 68 | 0.480 |
Why?
| | DNA Damage | 1 | 2018 | 383 | 0.480 |
Why?
| | Telemetry | 1 | 2015 | 39 | 0.470 |
Why?
| | Cosmic Radiation | 1 | 2014 | 6 | 0.470 |
Why?
| | Cytokines | 9 | 2019 | 2018 | 0.470 |
Why?
| | ADAM Proteins | 3 | 2022 | 59 | 0.470 |
Why?
| | Mice, Transgenic | 8 | 2022 | 2135 | 0.460 |
Why?
| | Female | 35 | 2024 | 68650 | 0.450 |
Why?
| | Oxidoreductases | 4 | 2011 | 92 | 0.450 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 83 | 0.450 |
Why?
| | Transcytosis | 1 | 2014 | 7 | 0.450 |
Why?
| | Alginates | 1 | 2014 | 46 | 0.440 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2013 | 282 | 0.440 |
Why?
| | Palmitic Acids | 1 | 2014 | 9 | 0.440 |
Why?
| | Receptors, Lysosphingolipid | 2 | 2014 | 13 | 0.440 |
Why?
| | Caspase Inhibitors | 3 | 2011 | 81 | 0.430 |
Why?
| | Thoracic Vertebrae | 1 | 2014 | 73 | 0.430 |
Why?
| | Cell Proliferation | 9 | 2020 | 2367 | 0.430 |
Why?
| | Nicotinic Agonists | 1 | 2015 | 121 | 0.430 |
Why?
| | Spinal Injuries | 1 | 2014 | 51 | 0.430 |
Why?
| | Enzyme Activation | 8 | 2015 | 806 | 0.430 |
Why?
| | Stem Cell Transplantation | 2 | 2015 | 166 | 0.420 |
Why?
| | Trypsin Inhibitors | 2 | 2017 | 6 | 0.400 |
Why?
| | Interleukin-6 | 1 | 2016 | 724 | 0.400 |
Why?
| | Lysophospholipids | 5 | 2015 | 72 | 0.400 |
Why?
| | Nicotine | 1 | 2015 | 304 | 0.400 |
Why?
| | Tracheostomy | 1 | 2014 | 129 | 0.390 |
Why?
| | Pseudomonas Infections | 1 | 2014 | 222 | 0.380 |
Why?
| | Cystic Fibrosis | 2 | 2014 | 1067 | 0.380 |
Why?
| | Metabolomics | 5 | 2018 | 652 | 0.370 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 348 | 0.370 |
Why?
| | Estrogens | 1 | 2014 | 346 | 0.360 |
Why?
| | Photons | 1 | 2011 | 67 | 0.350 |
Why?
| | Exercise Therapy | 1 | 2015 | 414 | 0.350 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2021 | 52 | 0.350 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 311 | 0.350 |
Why?
| | Cell Differentiation | 2 | 2018 | 1895 | 0.350 |
Why?
| | Stress, Physiological | 1 | 2014 | 411 | 0.350 |
Why?
| | Virus Diseases | 2 | 2023 | 210 | 0.340 |
Why?
| | Adult Stem Cells | 1 | 2010 | 39 | 0.330 |
Why?
| | Hemodynamics | 1 | 2015 | 1094 | 0.330 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2014 | 2013 | 0.330 |
Why?
| | Pancreatic Elastase | 2 | 2021 | 60 | 0.330 |
Why?
| | Caspases | 3 | 2011 | 245 | 0.320 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2024 | 182 | 0.310 |
Why?
| | Phenotype | 7 | 2020 | 3058 | 0.300 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2021 | 393 | 0.300 |
Why?
| | Superoxide Dismutase | 3 | 2020 | 342 | 0.300 |
Why?
| | Fingolimod Hydrochloride | 3 | 2022 | 39 | 0.300 |
Why?
| | Vascular Remodeling | 4 | 2025 | 189 | 0.300 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 326 | 0.290 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 539 | 0.280 |
Why?
| | Mass Spectrometry | 4 | 2018 | 717 | 0.280 |
Why?
| | Fibrinolysin | 1 | 2007 | 17 | 0.270 |
Why?
| | Transcription Factors | 2 | 2012 | 1642 | 0.270 |
Why?
| | Heart | 1 | 2011 | 643 | 0.270 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1438 | 0.270 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2016 | 144 | 0.270 |
Why?
| | Lipopolysaccharides | 4 | 2023 | 872 | 0.260 |
Why?
| | RNA, Small Interfering | 3 | 2018 | 590 | 0.260 |
Why?
| | Biomarkers | 8 | 2021 | 3968 | 0.260 |
Why?
| | Thrombin | 1 | 2007 | 147 | 0.260 |
Why?
| | Electric Impedance | 3 | 2015 | 102 | 0.250 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 4 | 2012 | 107 | 0.250 |
Why?
| | Gene Expression Regulation | 5 | 2020 | 2544 | 0.250 |
Why?
| | ADAM17 Protein | 2 | 2017 | 33 | 0.240 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 191 | 0.240 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 317 | 0.240 |
Why?
| | Leukocytes | 3 | 2022 | 304 | 0.240 |
Why?
| | Cell Adhesion | 2 | 2020 | 454 | 0.230 |
Why?
| | Caspase 6 | 2 | 2016 | 3 | 0.230 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2015 | 131 | 0.230 |
Why?
| | Caspase 7 | 2 | 2016 | 22 | 0.230 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2503 | 0.230 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 650 | 0.220 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 22 | 0.210 |
Why?
| | Capillary Permeability | 2 | 2015 | 140 | 0.210 |
Why?
| | Homeostasis | 3 | 2018 | 605 | 0.210 |
Why?
| | Cell Culture Techniques | 2 | 2019 | 347 | 0.210 |
Why?
| | Biomedical Technology | 1 | 2024 | 42 | 0.210 |
Why?
| | Receptors, CXCR3 | 2 | 2013 | 16 | 0.210 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2003 | 20 | 0.210 |
Why?
| | Pulmonary Medicine | 1 | 2024 | 80 | 0.210 |
Why?
| | Monocytes | 4 | 2023 | 554 | 0.210 |
Why?
| | rho GTP-Binding Proteins | 1 | 2003 | 59 | 0.200 |
Why?
| | Cell Line | 4 | 2017 | 2774 | 0.200 |
Why?
| | Middle Aged | 11 | 2022 | 31087 | 0.200 |
Why?
| | Respiratory System | 1 | 2024 | 155 | 0.200 |
Why?
| | Oxygen Consumption | 2 | 2022 | 663 | 0.190 |
Why?
| | Cell Adhesion Molecules | 2 | 2015 | 173 | 0.190 |
Why?
| | X-Ray Microtomography | 2 | 2022 | 84 | 0.190 |
Why?
| | Primary Cell Culture | 2 | 2013 | 164 | 0.190 |
Why?
| | Congresses as Topic | 1 | 2023 | 215 | 0.190 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1248 | 0.180 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 247 | 0.180 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 11 | 0.180 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 8 | 0.180 |
Why?
| | Flow Cytometry | 4 | 2015 | 1158 | 0.180 |
Why?
| | Influenza A virus | 1 | 2022 | 100 | 0.180 |
Why?
| | Chitinases | 1 | 2021 | 9 | 0.180 |
Why?
| | Societies, Medical | 2 | 2023 | 757 | 0.180 |
Why?
| | CD11 Antigens | 1 | 2021 | 30 | 0.180 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2021 | 39 | 0.180 |
Why?
| | Cell Size | 1 | 2021 | 89 | 0.180 |
Why?
| | CD11b Antigen | 1 | 2021 | 60 | 0.180 |
Why?
| | Cytoskeleton | 3 | 2011 | 181 | 0.180 |
Why?
| | Lectins | 1 | 2021 | 48 | 0.180 |
Why?
| | Kinetics | 3 | 2015 | 1641 | 0.180 |
Why?
| | Risk Factors | 5 | 2024 | 9779 | 0.180 |
Why?
| | Protein Inhibitors of Activated STAT | 1 | 2020 | 6 | 0.170 |
Why?
| | Dronabinol | 1 | 2023 | 203 | 0.170 |
Why?
| | Inhalation Exposure | 1 | 2021 | 92 | 0.170 |
Why?
| | Endothelial Progenitor Cells | 1 | 2020 | 20 | 0.170 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2020 | 28 | 0.170 |
Why?
| | Microtubules | 1 | 2003 | 264 | 0.170 |
Why?
| | Integrin beta1 | 1 | 2020 | 22 | 0.170 |
Why?
| | Blotting, Western | 4 | 2011 | 1199 | 0.170 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 275 | 0.170 |
Why?
| | Receptors, CXCR4 | 2 | 2018 | 83 | 0.170 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2020 | 69 | 0.170 |
Why?
| | Stem Cell Niche | 1 | 2020 | 53 | 0.170 |
Why?
| | Lactic Acid | 1 | 2022 | 304 | 0.170 |
Why?
| | Tobacco Smoking | 1 | 2020 | 25 | 0.170 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2020 | 65 | 0.170 |
Why?
| | Stromal Cells | 2 | 2017 | 106 | 0.160 |
Why?
| | Sirolimus | 1 | 2021 | 270 | 0.160 |
Why?
| | Ischemia | 2 | 2018 | 405 | 0.160 |
Why?
| | Oxidants | 2 | 2011 | 108 | 0.160 |
Why?
| | Biological Assay | 2 | 2021 | 119 | 0.160 |
Why?
| | Cell Membrane | 3 | 2013 | 733 | 0.160 |
Why?
| | Collagen Type V | 2 | 2009 | 3 | 0.160 |
Why?
| | Case-Control Studies | 2 | 2017 | 3383 | 0.160 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2020 | 157 | 0.150 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2019 | 20 | 0.150 |
Why?
| | Exercise Test | 1 | 2022 | 608 | 0.150 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 169 | 0.150 |
Why?
| | Serine C-Palmitoyltransferase | 3 | 2008 | 8 | 0.150 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2020 | 373 | 0.150 |
Why?
| | Fatty Acids | 1 | 2022 | 427 | 0.150 |
Why?
| | beta Catenin | 1 | 2020 | 224 | 0.150 |
Why?
| | Paclitaxel | 2 | 2014 | 217 | 0.150 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2013 | 161 | 0.150 |
Why?
| | Hot Temperature | 1 | 2021 | 369 | 0.150 |
Why?
| | Cell Survival | 3 | 2018 | 1084 | 0.150 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2014 | 186 | 0.150 |
Why?
| | Eosinophils | 1 | 2021 | 324 | 0.150 |
Why?
| | Databases, Chemical | 1 | 2018 | 6 | 0.150 |
Why?
| | Benzylamines | 1 | 2018 | 41 | 0.150 |
Why?
| | Oxygen | 2 | 2014 | 914 | 0.150 |
Why?
| | Parenchymal Tissue | 1 | 2018 | 6 | 0.150 |
Why?
| | Imipramine | 1 | 2018 | 12 | 0.150 |
Why?
| | Estrogen Receptor beta | 1 | 2018 | 37 | 0.150 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 42 | 0.140 |
Why?
| | Morphine | 2 | 2009 | 138 | 0.140 |
Why?
| | Chemokine CXCL12 | 1 | 2018 | 79 | 0.140 |
Why?
| | Gene Expression | 2 | 2021 | 1461 | 0.140 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 139 | 0.140 |
Why?
| | Adult | 10 | 2022 | 35505 | 0.140 |
Why?
| | Academic Medical Centers | 1 | 2020 | 478 | 0.140 |
Why?
| | Carbon Monoxide | 1 | 2018 | 68 | 0.140 |
Why?
| | Cell Hypoxia | 4 | 2020 | 226 | 0.140 |
Why?
| | Disease Outbreaks | 1 | 2020 | 349 | 0.140 |
Why?
| | Leukocyte Elastase | 1 | 2017 | 77 | 0.140 |
Why?
| | Neovascularization, Pathologic | 2 | 2012 | 292 | 0.140 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 535 | 0.130 |
Why?
| | Transcriptome | 3 | 2018 | 875 | 0.130 |
Why?
| | Bone Marrow | 1 | 2018 | 272 | 0.130 |
Why?
| | THP-1 Cells | 1 | 2016 | 22 | 0.130 |
Why?
| | High-Intensity Interval Training | 1 | 2016 | 24 | 0.130 |
Why?
| | Spinal Cord | 2 | 2009 | 352 | 0.130 |
Why?
| | Adipocytes | 1 | 2018 | 205 | 0.130 |
Why?
| | Time Factors | 3 | 2018 | 6530 | 0.130 |
Why?
| | Sleep Apnea Syndromes | 1 | 2017 | 82 | 0.130 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2011 | 311 | 0.130 |
Why?
| | Lung Transplantation | 2 | 2009 | 290 | 0.130 |
Why?
| | Protein Binding | 3 | 2018 | 2121 | 0.120 |
Why?
| | Bronchi | 1 | 2017 | 249 | 0.120 |
Why?
| | Pandemics | 2 | 2021 | 1500 | 0.120 |
Why?
| | Protein Kinases | 1 | 2018 | 314 | 0.120 |
Why?
| | Aging | 2 | 2021 | 1770 | 0.120 |
Why?
| | Plasma | 1 | 2017 | 206 | 0.120 |
Why?
| | Monocrotaline | 1 | 2015 | 28 | 0.120 |
Why?
| | I-kappa B Proteins | 2 | 2013 | 79 | 0.120 |
Why?
| | Mice, 129 Strain | 2 | 2012 | 87 | 0.120 |
Why?
| | Neutrophils | 1 | 2021 | 1209 | 0.120 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2015 | 51 | 0.120 |
Why?
| | Actins | 3 | 2018 | 406 | 0.120 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 367 | 0.120 |
Why?
| | Ventricular Pressure | 1 | 2015 | 45 | 0.120 |
Why?
| | Delivery of Health Care | 1 | 2022 | 896 | 0.120 |
Why?
| | Myelopoiesis | 1 | 2015 | 7 | 0.120 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.120 |
Why?
| | Binding, Competitive | 1 | 2015 | 206 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 382 | 0.120 |
Why?
| | Cathepsin E | 1 | 2014 | 1 | 0.120 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 140 | 0.120 |
Why?
| | Cell Membrane Permeability | 1 | 2015 | 82 | 0.120 |
Why?
| | Culture Media, Conditioned | 1 | 2015 | 109 | 0.120 |
Why?
| | Collagen Type VI | 1 | 2014 | 6 | 0.110 |
Why?
| | Immunoblotting | 1 | 2015 | 303 | 0.110 |
Why?
| | Hexuronic Acids | 1 | 2014 | 23 | 0.110 |
Why?
| | Glucuronic Acid | 1 | 2014 | 25 | 0.110 |
Why?
| | Polysaccharide-Lyases | 1 | 2014 | 11 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2734 | 0.110 |
Why?
| | Arterial Pressure | 1 | 2015 | 119 | 0.110 |
Why?
| | Mice, Inbred C3H | 1 | 2014 | 271 | 0.110 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2015 | 201 | 0.110 |
Why?
| | Mitochondrial Dynamics | 1 | 2014 | 37 | 0.110 |
Why?
| | Propylene Glycols | 2 | 2014 | 27 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2010 | 443 | 0.110 |
Why?
| | Hyperoxia | 1 | 2015 | 90 | 0.110 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2014 | 66 | 0.110 |
Why?
| | Dehydroepiandrosterone | 1 | 2014 | 51 | 0.110 |
Why?
| | Metabolome | 1 | 2017 | 338 | 0.110 |
Why?
| | Asthma | 2 | 2020 | 2225 | 0.110 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2016 | 231 | 0.110 |
Why?
| | Ligands | 3 | 2023 | 619 | 0.110 |
Why?
| | HMGB1 Protein | 1 | 2014 | 49 | 0.110 |
Why?
| | Paracrine Communication | 1 | 2014 | 59 | 0.110 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2013 | 57 | 0.110 |
Why?
| | HIV Infections | 3 | 2017 | 2729 | 0.110 |
Why?
| | Ventricular Remodeling | 2 | 2015 | 256 | 0.110 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2013 | 53 | 0.110 |
Why?
| | United States | 4 | 2024 | 13865 | 0.110 |
Why?
| | Oligopeptides | 2 | 2014 | 260 | 0.110 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 198 | 0.100 |
Why?
| | Glycolysis | 1 | 2015 | 313 | 0.100 |
Why?
| | Virulence | 1 | 2014 | 255 | 0.100 |
Why?
| | Calpain | 1 | 2013 | 57 | 0.100 |
Why?
| | Glycerylphosphorylcholine | 1 | 2013 | 6 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2006 | 527 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 409 | 0.100 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2013 | 36 | 0.100 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 1950 | 0.100 |
Why?
| | Dermatitis, Contact | 1 | 2013 | 17 | 0.100 |
Why?
| | Bronchitis, Chronic | 1 | 2013 | 19 | 0.100 |
Why?
| | Platelet Activating Factor | 1 | 2013 | 75 | 0.100 |
Why?
| | Ventricular Function, Right | 1 | 2015 | 276 | 0.100 |
Why?
| | Cattle | 3 | 2008 | 959 | 0.100 |
Why?
| | MAP Kinase Signaling System | 2 | 2012 | 312 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2062 | 0.100 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2013 | 44 | 0.100 |
Why?
| | Lung Compliance | 1 | 2012 | 48 | 0.100 |
Why?
| | Proteolysis | 1 | 2013 | 167 | 0.100 |
Why?
| | Neuralgia | 1 | 2014 | 127 | 0.100 |
Why?
| | Liposomes | 1 | 2014 | 171 | 0.100 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5078 | 0.100 |
Why?
| | Drug Tolerance | 2 | 2009 | 89 | 0.100 |
Why?
| | Estrogen Antagonists | 1 | 2012 | 45 | 0.090 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 74 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 427 | 0.090 |
Why?
| | Airway Remodeling | 1 | 2012 | 63 | 0.090 |
Why?
| | Cardiac Output | 1 | 2012 | 157 | 0.090 |
Why?
| | Atmosphere Exposure Chambers | 1 | 2011 | 6 | 0.090 |
Why?
| | Catalase | 1 | 2011 | 128 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2014 | 1286 | 0.090 |
Why?
| | Polymerase Chain Reaction | 2 | 2015 | 1031 | 0.090 |
Why?
| | Bronchioles | 1 | 2011 | 23 | 0.090 |
Why?
| | Goblet Cells | 1 | 2011 | 22 | 0.090 |
Why?
| | Microcirculation | 1 | 2011 | 145 | 0.090 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2011 | 149 | 0.090 |
Why?
| | Analgesics, Opioid | 2 | 2009 | 919 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2013 | 368 | 0.090 |
Why?
| | Permeability | 1 | 2011 | 158 | 0.090 |
Why?
| | Immunization, Passive | 1 | 2011 | 86 | 0.090 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 206 | 0.090 |
Why?
| | Inflammasomes | 1 | 2012 | 126 | 0.090 |
Why?
| | Ceramidases | 1 | 2010 | 4 | 0.090 |
Why?
| | Carcinogens | 1 | 2011 | 109 | 0.090 |
Why?
| | Testosterone | 1 | 2014 | 371 | 0.090 |
Why?
| | Phosphorylation | 1 | 2015 | 1714 | 0.090 |
Why?
| | Acetylcysteine | 1 | 2011 | 145 | 0.090 |
Why?
| | Jurkat Cells | 1 | 2010 | 134 | 0.090 |
Why?
| | Aged | 5 | 2020 | 22063 | 0.090 |
Why?
| | Mice, Inbred Strains | 1 | 2011 | 408 | 0.090 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2010 | 52 | 0.090 |
Why?
| | Stem Cells | 1 | 2015 | 574 | 0.090 |
Why?
| | Plant Extracts | 1 | 2012 | 198 | 0.090 |
Why?
| | Exercise | 1 | 2022 | 1931 | 0.080 |
Why?
| | Perfusion | 1 | 2011 | 197 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 2014 | 520 | 0.080 |
Why?
| | Transplantation, Heterologous | 1 | 2010 | 190 | 0.080 |
Why?
| | Biosensing Techniques | 1 | 2011 | 118 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2017 | 2697 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 981 | 0.080 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 42 | 0.080 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2012 | 398 | 0.080 |
Why?
| | Posterior Horn Cells | 1 | 2009 | 9 | 0.080 |
Why?
| | Pulmonary Circulation | 1 | 2011 | 428 | 0.080 |
Why?
| | Mutation | 1 | 2020 | 3702 | 0.080 |
Why?
| | Clathrin | 1 | 2009 | 26 | 0.080 |
Why?
| | Oxidation-Reduction | 3 | 2022 | 1029 | 0.080 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1684 | 0.080 |
Why?
| | Transplantation Tolerance | 1 | 2009 | 35 | 0.080 |
Why?
| | Peptide Fragments | 1 | 2013 | 695 | 0.080 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 92 | 0.080 |
Why?
| | Transplantation, Homologous | 1 | 2010 | 402 | 0.080 |
Why?
| | Peroxynitrous Acid | 1 | 2008 | 13 | 0.080 |
Why?
| | Cell Line, Tumor | 3 | 2011 | 3181 | 0.080 |
Why?
| | Heart Ventricles | 1 | 2014 | 778 | 0.080 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2006 | 79 | 0.080 |
Why?
| | Software | 1 | 2013 | 608 | 0.080 |
Why?
| | Transcription, Genetic | 2 | 2013 | 1416 | 0.080 |
Why?
| | Protein Precursors | 1 | 2009 | 128 | 0.080 |
Why?
| | Histocompatibility Antigens | 1 | 2009 | 107 | 0.080 |
Why?
| | Immunosuppressive Agents | 2 | 2014 | 858 | 0.080 |
Why?
| | Pyrroles | 1 | 2009 | 201 | 0.080 |
Why?
| | Superoxide Dismutase-1 | 1 | 2008 | 10 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 804 | 0.070 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2008 | 35 | 0.070 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2020 | 257 | 0.070 |
Why?
| | Sex Factors | 1 | 2014 | 1966 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 277 | 0.070 |
Why?
| | Cyclosporine | 1 | 2009 | 263 | 0.070 |
Why?
| | Glycerophospholipids | 2 | 2018 | 34 | 0.070 |
Why?
| | Patch-Clamp Techniques | 1 | 2009 | 278 | 0.070 |
Why?
| | Obesity | 2 | 2020 | 2875 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 249 | 0.070 |
Why?
| | Transglutaminases | 1 | 2008 | 153 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2009 | 363 | 0.070 |
Why?
| | Caspase 9 | 2 | 2008 | 56 | 0.070 |
Why?
| | Superoxides | 1 | 2008 | 201 | 0.070 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 317 | 0.070 |
Why?
| | Organ Size | 1 | 2008 | 455 | 0.070 |
Why?
| | Antibody Formation | 1 | 2008 | 291 | 0.070 |
Why?
| | Antiviral Agents | 2 | 2023 | 719 | 0.070 |
Why?
| | Cell-Free System | 1 | 2006 | 48 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2020 | 2421 | 0.070 |
Why?
| | Indoles | 1 | 2009 | 387 | 0.070 |
Why?
| | Cisplatin | 1 | 2008 | 298 | 0.060 |
Why?
| | Capillaries | 1 | 2006 | 103 | 0.060 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 1050 | 0.060 |
Why?
| | Antigens, CD | 2 | 2011 | 485 | 0.060 |
Why?
| | Graft Rejection | 1 | 2009 | 598 | 0.060 |
Why?
| | Fumonisins | 1 | 2005 | 3 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1636 | 0.060 |
Why?
| | Adenoviridae | 1 | 2006 | 190 | 0.060 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2005 | 53 | 0.060 |
Why?
| | Weight Loss | 1 | 2010 | 738 | 0.060 |
Why?
| | Acyltransferases | 1 | 2005 | 55 | 0.060 |
Why?
| | Regeneration | 1 | 2006 | 182 | 0.060 |
Why?
| | Blood Pressure | 1 | 2012 | 1735 | 0.060 |
Why?
| | Deoxyguanosine | 1 | 2004 | 25 | 0.060 |
Why?
| | Disease Progression | 1 | 2012 | 2628 | 0.060 |
Why?
| | Immunoglobulin G | 1 | 2008 | 851 | 0.060 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 19 | 0.050 |
Why?
| | Supreme Court Decisions | 1 | 2023 | 11 | 0.050 |
Why?
| | Stress Fibers | 1 | 2003 | 18 | 0.050 |
Why?
| | Adherens Junctions | 1 | 2003 | 25 | 0.050 |
Why?
| | Caspase 8 | 1 | 2003 | 48 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2003 | 86 | 0.050 |
Why?
| | Ovarian Neoplasms | 1 | 2008 | 482 | 0.050 |
Why?
| | Myosins | 1 | 2003 | 133 | 0.050 |
Why?
| | rho-Associated Kinases | 1 | 2003 | 85 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1366 | 0.050 |
Why?
| | Sphingomyelins | 2 | 2015 | 29 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 274 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 392 | 0.050 |
Why?
| | Imidazoles | 1 | 2003 | 235 | 0.050 |
Why?
| | Cell Communication | 1 | 2023 | 298 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2342 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2023 | 381 | 0.050 |
Why?
| | Autophagosomes | 1 | 2021 | 19 | 0.040 |
Why?
| | Epithelium | 1 | 2022 | 311 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 42 | 0.040 |
Why?
| | Antineoplastic Agents | 2 | 2009 | 2044 | 0.040 |
Why?
| | Autoantibodies | 1 | 2008 | 1468 | 0.040 |
Why?
| | Fever | 1 | 2022 | 298 | 0.040 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2020 | 8 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 109 | 0.040 |
Why?
| | Transcription Factor RelA | 1 | 2020 | 85 | 0.040 |
Why?
| | Neurons | 1 | 2008 | 1509 | 0.040 |
Why?
| | Pyridines | 1 | 2003 | 478 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 101 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2023 | 740 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 754 | 0.040 |
Why?
| | Propensity Score | 1 | 2020 | 266 | 0.040 |
Why?
| | Rats, Inbred WKY | 2 | 2009 | 35 | 0.040 |
Why?
| | Cohort Studies | 2 | 2020 | 5423 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2020 | 673 | 0.040 |
Why?
| | Swine | 1 | 2021 | 760 | 0.040 |
Why?
| | Cell Lineage | 1 | 2020 | 332 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2020 | 349 | 0.040 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2018 | 21 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2020 | 239 | 0.040 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2018 | 21 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2022 | 500 | 0.040 |
Why?
| | Propionates | 1 | 2018 | 38 | 0.040 |
Why?
| | Odds Ratio | 1 | 2020 | 1018 | 0.040 |
Why?
| | Protein Stability | 1 | 2018 | 162 | 0.040 |
Why?
| | Vital Capacity | 1 | 2018 | 290 | 0.040 |
Why?
| | Betacoronavirus | 1 | 2020 | 252 | 0.030 |
Why?
| | Nitriles | 1 | 2018 | 169 | 0.030 |
Why?
| | Estrogen Receptor alpha | 1 | 2018 | 129 | 0.030 |
Why?
| | Sample Size | 1 | 2017 | 116 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1053 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1326 | 0.030 |
Why?
| | RNA | 1 | 2023 | 876 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 732 | 0.030 |
Why?
| | HIV | 1 | 2017 | 227 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 235 | 0.030 |
Why?
| | Weight Gain | 1 | 2020 | 510 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 121 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1722 | 0.030 |
Why?
| | Antioxidants | 2 | 2013 | 557 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 342 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 1983 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 336 | 0.030 |
Why?
| | NF-kappa B | 2 | 2010 | 666 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Physical Endurance | 1 | 2016 | 263 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2015 | 142 | 0.030 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2015 | 77 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 55 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 12438 | 0.030 |
Why?
| | Interleukin-23 Subunit p19 | 1 | 2014 | 6 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 105 | 0.030 |
Why?
| | Quinazolinones | 1 | 2014 | 19 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 996 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 135 | 0.030 |
Why?
| | Indans | 1 | 2014 | 10 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2022 | 14532 | 0.030 |
Why?
| | Oxadiazoles | 1 | 2014 | 32 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 134 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2015 | 324 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 525 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2016 | 236 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 350 | 0.030 |
Why?
| | Anilides | 1 | 2014 | 70 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 581 | 0.030 |
Why?
| | Thiazoles | 1 | 2014 | 118 | 0.030 |
Why?
| | Organophosphonates | 1 | 2014 | 92 | 0.030 |
Why?
| | Cricetulus | 1 | 2013 | 107 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2020 | 790 | 0.030 |
Why?
| | Phosphatidylserines | 1 | 2014 | 88 | 0.030 |
Why?
| | Thiophenes | 1 | 2014 | 117 | 0.030 |
Why?
| | CHO Cells | 1 | 2013 | 155 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1594 | 0.030 |
Why?
| | Cricetinae | 1 | 2013 | 280 | 0.030 |
Why?
| | Dinitrofluorobenzene | 1 | 2013 | 6 | 0.030 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 2013 | 21 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 587 | 0.030 |
Why?
| | Lipid Bilayers | 1 | 2014 | 97 | 0.030 |
Why?
| | Phosphatidylcholines | 1 | 2014 | 145 | 0.030 |
Why?
| | Culture Media, Serum-Free | 1 | 2012 | 48 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 151 | 0.020 |
Why?
| | Lymphocyte Depletion | 1 | 2013 | 134 | 0.020 |
Why?
| | Hydrolases | 1 | 2013 | 56 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2015 | 827 | 0.020 |
Why?
| | Chemokine CXCL10 | 1 | 2012 | 36 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2013 | 174 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 546 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 184 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2015 | 503 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 315 | 0.020 |
Why?
| | Tyrosine | 1 | 2012 | 222 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2020 | 1168 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 937 | 0.020 |
Why?
| | Metaplasia | 1 | 2011 | 57 | 0.020 |
Why?
| | Mucus | 1 | 2011 | 77 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2014 | 506 | 0.020 |
Why?
| | Blood Glucose | 1 | 2020 | 2071 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1842 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 372 | 0.020 |
Why?
| | Th2 Cells | 1 | 2011 | 171 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2009 | 111 | 0.020 |
Why?
| | Rats, Inbred BN | 1 | 2009 | 58 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2009 | 82 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2313 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 121 | 0.020 |
Why?
| | Transplantation, Isogeneic | 1 | 2008 | 17 | 0.020 |
Why?
| | Spleen | 1 | 2011 | 508 | 0.020 |
Why?
| | X-Linked Inhibitor of Apoptosis Protein | 1 | 2008 | 12 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2009 | 224 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2008 | 91 | 0.020 |
Why?
| | Isoxazoles | 1 | 2008 | 54 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1261 | 0.020 |
Why?
| | GTP-Binding Proteins | 1 | 2008 | 158 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7052 | 0.020 |
Why?
| | Administration, Oral | 1 | 2009 | 783 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2009 | 804 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 1037 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1614 | 0.020 |
Why?
| | Postural Balance | 1 | 2008 | 198 | 0.020 |
Why?
| | Pleura | 1 | 2005 | 22 | 0.020 |
Why?
| | Ligation | 1 | 2005 | 86 | 0.020 |
Why?
| | In Situ Nick-End Labeling | 1 | 2004 | 123 | 0.010 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 111 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2008 | 816 | 0.010 |
Why?
| | Pulmonary Embolism | 1 | 2005 | 212 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 397 | 0.010 |
Why?
| | Endopeptidases | 1 | 2003 | 85 | 0.010 |
Why?
| | Peptides | 1 | 2008 | 925 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2011 | 1935 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 10232 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1717 | 0.010 |
Why?
| | Child | 1 | 2017 | 20932 | 0.010 |
Why?
|
|
Petrache's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|